| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5bc5292a07e34d16eb1d033a16d3aec3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-87 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-96 |
| filingDate |
2014-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_620b3220585bae0d8972f3e2c9e7b13c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0dd6e2b4c7dd673df5938a2f69596d49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9aececb153d23f26f46b8785beef1e99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d9eb6b3b58496c1474384eaeb3c7d31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8991778afdc36893526c5969720930a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_014cfedabbc6c43a0c5378ac8ae0354d |
| publicationDate |
2022-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2915817-C |
| titleOfInvention |
Substituted (e)-n'-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors |
| abstract |
In one aspect, the invention relates to a compound having a structure represented by a formula (II) wherein m is 0 or 1; or a pharmaceutically acceptable salt thereof. Such a compound can be useful for the treatment of a disorder of uncontrolled cellular proliferation in a mammal. It can also be used for decreasing histone demethylase activity in a mammal. |
| priorityDate |
2013-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |